NXGL
NEXGEL, INC.
Latest Form 4:Sale$4KbyLevy Adam R. (Chief Executive Officer) · filed Jun 23, 2026
NEXGEL, INC. (NXGL) has 10 SEC Form 4 filings (17 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jun 23, 2026.
The most active filer is Chief Executive Officer Levy Adam R. with 14 filings.
- Industry:Medical - Instruments & Supplies
- CEO:Adam R. Levy
- Employees:19
- HQ:Langhorne, PA, US
- IPO:2021-12-22
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$95K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$3.4M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 6,000 | $4K | Jun 23 | SEC ↗ | |
| Chief Executive Officer | Sale | 5,000 | $3K | Jun 23 | SEC ↗ | |
| Chief Executive Officer | Sale | 3,000 | $2K | Jun 15 | SEC ↗ | |
| Chief Executive Officer | Sale | 3,000 | $2K | Jun 9 | SEC ↗ | |
| Chief Executive Officer | Sale | 3,000 | $2K | Jun 9 | SEC ↗ | |
| Chief Executive Officer | Sale | 2,000 | $1K | Jun 3 | SEC ↗ | |
Levy Adam R.First in 5 months | Chief Executive Officer | Sale | 3,000 | $2K | May 30 | SEC ↗ |
Levy Adam R.First in 5 months | Chief Executive Officer | Sale | 7,000 | $4K | May 30 | SEC ↗ |
Levy Adam R.First in 5 months | Chief Executive Officer | Sale | 3,000 | $2K | May 30 | SEC ↗ |
| Chief Executive Officer | Sale | 6,000 | $10K | Dec 29 | SEC ↗ | |
| Chief Executive Officer | Sale | 4,000 | $6K | Dec 29 | SEC ↗ | |
| Chief Executive Officer | Sale | 4,000 | $10K | Nov 7 | SEC ↗ | |
| Director | Sale | 825 | $2K | Oct 6 | SEC ↗ | |
| Director | Sale | 7,175 | $18K | Oct 6 | SEC ↗ | |
Levy Adam R.First filing | Chief Executive Officer | Sale | 1,600 | $4K | Oct 6 | SEC ↗ |
Levy Adam R.First filing | Chief Executive Officer | Sale | 2,400 | $6K | Oct 6 | SEC ↗ |
Henry Scott RobertFirst filing | Director | Sale | 7,697 | $18K | Sep 29 | SEC ↗ |
Related companies
NEXGEL, INC. is in the Healthcare sector.